GHK Basic 200mg (Tripeptide-1) (Topical)

GHK is a tripeptide with the amino acid sequence glycyl-histidyl-lysine. In preclinical research, GHK is used as a tool compound to evaluate peptide-driven modulation of cellular stress-response programs, extracellular matrix (ECM)-associated transcriptional networks, and metal-ion (Cu) complexation effects. GHK is frequently studied both as the free tripeptide and as a copper complex (GHK-Cu) to compare how transition-metal coordination influences physicochemical behavior and downstream signaling readouts in cellular and in vivo model systems.

Identity: GHK (Glycyl-Histidyl-Lysine), tripeptide
Complexation: Commonly evaluated as apo-GHK and as a Cu(II) coordination complex (GHK-Cu) in mechanistic studies

The histidine and terminal amine functionalities in GHK can coordinate metal ions, and copper complexation is used experimentally to probe how redox-active cofactors and peptide coordination chemistry impact protein-binding interactions, gene-expression signatures, and cellular oxidative-stress handling under controlled laboratory conditions.

• Transcriptomic profiling: Assessment of GHK-associated gene-expression changes across stress, proteostasis, inflammatory, and ECM-related pathways in cultured cells and preclinical models.
• Peptide–metal coordination studies: Comparative evaluation of apo-GHK vs GHK-Cu to examine how Cu(II) coordination alters peptide stability, binding behavior, and redox-associated pathway readouts.
• Proteostasis / UPS research: Use in studies examining ubiquitin–proteasome system (UPS) gene programs and protein quality-control signaling.
• ECM & remodeling models: Investigation of ECM transcriptional markers, matrix-associated proteins, and remodeling-associated signaling networks (including TGF superfamily-linked gene programs) in cell and animal models.
• Inflammation-related readouts: Evaluation of cytokine-linked mechanisms (e.g., IL-6-associated programs) and downstream acute-phase gene networks in relevant cellular systems.
• Insulin/IGF-like signaling exploration: Use as a mechanistic probe for insulin/IGF-like pathway gene sets in preclinical gene-expression datasets.

GHK vs GHK-Cu (conceptual distinction): In experimental designs, GHK is evaluated either as the free tripeptide or as a copper coordination complex (GHK-Cu). Copper coordination can influence peptide conformation, charge distribution, and redox behavior, which may shift pathway readouts in assays focused on oxidative-stress handling, transcriptional regulation, and matrix-associated signaling.

Copper as a redox-active cofactor: Copper is a transition metal used by numerous enzymes that rely on Cu(I)/Cu(II) interconversion to support electron-transfer chemistry. In biological systems, copper-dependent enzymes are involved in processes such as cellular respiration, antioxidant defense, and connective-tissue crosslinking. In RUO contexts, copper–peptide coordination is used to study how metal availability and ligand binding can affect pathway-level signaling and gene expression under controlled conditions.

ECM-linked peptide fragments: Short peptide motifs associated with matrix proteins (including sequences present in collagen-associated proteins such as SPARC) are frequently used as research tools to examine remodeling-associated programs and cell–matrix signaling. GHK is discussed in the literature as a motif relevant to matrix-associated turnover and remodeling models.

1. Fibrinogen / IL-6-Linked Gene Programs

Preclinical gene-expression analyses summarized in the referenced literature describe GHK-associated modulation of inflammatory and acute-phase signaling, including IL-6-linked programs and fibrinogen-chain gene sets (e.g., FGB). These observations are typically reported from in vitro cellular systems and transcriptomic datasets used to infer pathway-level effects.

2. Ubiquitin/Proteasome System (UPS)

Reported transcriptional datasets include enrichment of ubiquitin–proteasome system (UPS) gene programs, a pathway class central to protein quality control and removal of damaged proteins. RUO studies use these readouts to map proteostasis-linked responses in cultured cells under defined experimental perturbations.

3. DNA Repair Gene Sets

Published analyses describe associations between GHK exposure and altered expression of DNA repair-related genes in in vitro models. In an RUO setting, these data are used as mechanistic background for selecting endpoints and validating pathway enrichment rather than for any intended-use interpretation.

4. Oxidative-Stress / Antioxidant Gene Programs

Gene-expression summaries in the cited references report changes in antioxidant and oxidative-stress-associated gene panels following GHK or GHK-Cu exposure in experimental systems. Such datasets are frequently used to study redox-response signaling and copper-dependent effects in cell culture.

5. Insulin / IGF-Like Signaling Signatures

Transcriptomic analyses discussed in the cited literature include modulation of insulin/IGF-like pathway gene sets. In preclinical research, these signatures are typically evaluated as part of broader systems-biology analyses to understand pathway coupling between metabolism-linked networks and stress-response programs.

6. TGF Superfamily-Associated Remodeling Programs

The referenced publications discuss GHK-associated gene programs that intersect with TGF superfamily signaling, a pathway group that regulates cell differentiation, ECM remodeling, and tissue-architecture-related transcriptional responses in many model systems. RUO studies may use these observations to guide mechanistic hypotheses and downstream validation experiments.

7. Cancer-Related Gene-Set Reversal Analyses

The cited literature includes discussions of gene-expression signature analyses in which compounds (including GHK in specified in vitro conditions) are evaluated for their ability to reverse predefined disease-associated transcriptional patterns. In an RUO context, these approaches are used as computational and experimental tools for pathway mapping and hypothesis generation in oncology-related model systems, without implying any intended use.

Conclusion

Across the cited publications, GHK and GHK-Cu are described primarily as research tools for probing multi-pathway gene expression, including ECM remodeling, proteostasis (UPS), oxidative-stress responses, and growth-factor/cytokine-linked signaling. These observations derive from preclinical datasets (cell culture systems, transcriptomic analyses, and model-based investigations) and are used to inform experimental design, endpoint selection, and mechanistic interpretation [1–4].

Any pharmacokinetic, tolerability, or administration statements from nonclinical reports should be interpreted strictly as preclinical background for experimental planning and are not indicative of suitability for any intended-use context.